Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00380796 · ClinicalTrials.gov registry record
A Long-term Safety Study of Infliximab in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD).
A clinical trial of COPD and Pulmonary Disease, Chronic Obstructive, sponsored by Centocor.
- Completed
- Registry status
- 88
- Enrollment target
- 20
- Study locations
NCT00380796: Completed study of COPD and Pulmonary Disease, Chronic Obstructive, sponsored by Centocor.
NCT00380796 is a study of COPD and Pulmonary Disease, Chronic Obstructive that has completed, run by Centocor. The registered enrollment target is 88 participants, below the 2,417-participant average among 85 other COPD trials with a reported enrollment target (96% lower). The trial reports 20 study locations across 14 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00380796, a study of COPD and Pulmonary Disease, Chronic Obstructive, has completed, sponsored by Centocor.
- COMPLETED
- Registry status
- 88 participants
- Enrollment target
- 20
- Study locations
Study Summary
The purpose of this long-term observational study is designed to collect additional information on incidence of cancer and cause of death among patients who have participated in clinical trials of infliximab in the treatment of COPD. Patients must have received at least 1 dose of study agent (ie, placebo or infliximab) in the primary studies to be eligible for participation in this long-term follow-up study. Information on deaths and cancers will be collected twice yearly for a period of 5 years from each patient's last safety visit in the primary study.
Conditions Studied
Interventions
- DRUG Collection of safety data for Cohort 1
Study Locations (20)
Pennsylvania
- - Easton
- - Hershey
- - Philadelphia
California
- - Anaheim
- - San Diego
Florida
- - Bay Pines
- - Clearwater
Missouri
- - Saint Charles
- - St Louis
New York
- - Endwell
- - Larchmont
Georgia
- - Blue Ridge
Maryland
- - Baltimore
Massachusetts
- - Springfield
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 88 participants |
| Start Date | 2006-04 |
| Est. Completion | 2009-12 |
What the finished NCT00380796 record still lists
NCT00380796 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 88 participants, a relatively small participant target, below the 2,417-participant average among 85 other COPD trials with a reported enrollment target (96% lower).
The record links to 2 conditions, with COPD appearing as the primary indexed condition, and to 1 intervention - of which Collection of safety data for Cohort 1 is the first listed.
NCT00380796 names 20 study sites across 14 states, led by Pennsylvania, California, Florida.
Frequently Asked Questions
What is clinical trial NCT00380796 about?
NCT00380796 is a clinical study titled "A Long-term Safety Study of Infliximab in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD).". The purpose of this long-term observational study is designed to collect additional information on incidence of cancer and cause of death among patients who have participated in clinical trials of infliximab in the treatment of COPD. Patients must have received at least 1 dose of study agent (ie, pl...
What is the current status of trial NCT00380796?
This trial is currently completed. The enrollment target is 88 participants. The study started on 2006-04. Estimated completion is 2009-12.
What conditions does trial NCT00380796 study?
This clinical trial studies the following conditions: COPD, Pulmonary Disease, Chronic Obstructive.
What interventions are being tested in trial NCT00380796?
The interventions under investigation include: Collection of safety data for Cohort 1 (DRUG).
Who is sponsoring clinical trial NCT00380796?
This trial is sponsored by Centocor, which has 33 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00380796 being conducted?
This trial has 20 study locations across California, Florida, Georgia, Maryland, Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for COPD
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00380796's enrollment target sits among peer trials
88 41st of 85 higher than 45 of 85 other COPD trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other COPD trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Impact of Positive Airway Pressure Therapy on Clinical Outcomes in Older Veterans With Chronic Obstructive Pulmonary Disease and Comorbid Obstructive Sleep Apnea (Overlap Syndrome)
RECRUITING · NA
-
Evaluating the Safety and Efficacy of dNerva Lung Denervation System in Patients With COPD
RECRUITING · NA
-
Pulmonary Hypertension SOLAR
RECRUITING · Phase 2
-
Hyperpolarized 129Xe MR Imaging of Lung Function in Healthy Volunteers and Subjects With Pulmonary Disease
RECRUITING · Phase 1
-
Home Hospital for Suddenly Ill Adults
RECRUITING · NA
-
Relationship of Inflammation and Pulmonary Function to Fungal Translocation in HIV
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03843463 · 88 participants · Phase 2
Escitalopram and Language Intervention for Subacute Aphasia
- NCT04066348 · 88 participants · Phase 2
TNF-α Treatment of Blast-Induced Tinnitus
- NCT04331704 · 88 participants · Phase 4
ANCHORS Alcohol & Sexual Health Study: UH3 Project
- NCT04536103 · 88 participants
Multi-Vendor Multi-Site Novel Accelerated MRI Relaxometry
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia